Benitec Biopharma Ltd Stock Investor Sentiment

BNTC Stock  USD 11.19  0.07  0.62%   
About 62% of Benitec Biopharma's investor base is looking to short. The analysis of the overall investor sentiment regarding Benitec Biopharma Ltd suggests that many traders are alarmed. The current market sentiment, together with Benitec Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Benitec Biopharma stock news signals to limit their universe of possible portfolio assets.
  
few days ago at finance.yahoo.com         
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b2a Cli...
Yahoo News
few days ago at seekingalpha.com         
Benitec reports Q2 results
seekingalpha News
few days ago at thelincolnianonline.com         
Benitec Biopharma Inc. Announces Q4 2024 Financial Results and Operational Update
news
few days ago at gurufocus.com         
Janus Henderson Group PLC Reduces Stake in Benitec Biopharma Inc
Gurufocus Stories at Macroaxis
over a week ago at simplywall.st         
Institutional investors are Benitec Biopharma Inc.s biggest bettors and were rewarded after last wee...
Simply Wall St News at Macroaxis
over three weeks ago at gurufocus.com         
Benitec Biopharma to Participate in Upcoming Conferences in January and February
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Franklin Resources Inc. Acquires Significant Stake in Benitec Biopharma Inc.
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
Benitec Biopharma Announces Three Major Conference Presentations for Early 2025 - StockTitan
Google News at Macroaxis
over three weeks ago at news.google.com         
Guggenheim Initiates Coverage of Benitec Biopharma with Buy Recommendation - MSN
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Why You Shouldnt Bet Against Benitec Biopharma Stock
Yahoo News
over a month ago at zacks.com         
Why You Shouldnt Bet Against Benitec Biopharma Stock
zacks News
over a month ago at thelincolnianonline.com         
Analysts Set Benitec Biopharma Inc. Target Price at 24.43
news
over a month ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over a month ago at www.macroaxis.com         
Acquisition by Suvretta Capital Management, Llc of 24360 shares of Benitec Biopharma at 10.98 subjec...
Macroaxis News
over a month ago at finance.yahoo.com         
Recent Price Trend in Benitec Biopharma is Your Friend, Heres Why
Yahoo News
Far too much social signal, news, headlines, and media speculation about Benitec Biopharma that are available to investors today. That information is available publicly through Benitec media outlets and privately through word of mouth or via Benitec internal channels. However, regardless of the origin, that massive amount of Benitec data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Benitec Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Benitec Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Benitec Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Benitec Biopharma alpha.

Benitec Biopharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Benitec Stock analysis

When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance